SiriusDecisions Summit Europe

October 10-11, 2019 | UK

SiriusDecisions Summit Europe is the must attend event for our community of sales, marketing and product innovators and trendsetters that drive growth in the most well-respected high-performing companies in the market today. We will showcase our theme; Achieving High Performance by Aligning the B-to-B Revenue Engine within our new agenda by applying it to our new models, frameworks and solutions — to enable our attendees to understand that achieving alignment means a more successful and brighter outcome than they ever imagined and it is the key formula the most successful organizations are applying to achieve accelerated-growth.

Spotlight

New data from an ongoing post-marketing study in nearly 45,000 people with non-valvular atrial fibrillation (NVAF) confirm the safety profile of XARELTO® (rivaroxaban) was generally consistent with the findings observed in ROCKET AF, the Phase 3 study that supported the approval of the medicine for prevention of stroke in patients with NVAF.


OTHER PAST CONFERENCES

Virtual Healthcare Compliance Symposium

April 28-29, 2022 | USA

The Virtual Healthcare Compliance Symposium 2022 will bring professionals from the healthcare and legal communities together for interesting discussion and online learning.

HIMSS EUROPEAN HEALTH CONFERENCE 2022

June 14-16, 2022 | USA

The conference will include sessions that will address the whole spectrum of the digital health ecosystem to reach key audiences in the sector: from hospital CEOs to innovative SMEs start-ups, as well as CMOs, clinicians, and nurses.

DHIS-Digital Healthcare Innovation Summit

February 2, 2022 | USA

Back for 2022 and coming to the west coast! Based on popular demand, Cambridge Healthtech Institute is adding an additional Digital Healthcare Innovation Summit (DHIS) to the West Coast in 2022 (DHIS-West). Like the original event (remaining in Boston in June 2022), this will be an unparalleled annual gathering of the leading innovators, investors, payers, providers and policymakers who are driving the digital health revolution. Join us for candid discussions (panels or 1-on-1 conversations) that explore relevant topics for digital health innovators and business leaders while networking in a tight community.

12th International Conference on Clinical Research And Clinical Trials

March 15-16, 2022 | USA

It’s an honour to welcome all the participants across the globe to be a part of“12thInternational Conference onClinical Research&Clinical Trials”during March 15-16, 2022 as a Webinar.

Spotlight

New data from an ongoing post-marketing study in nearly 45,000 people with non-valvular atrial fibrillation (NVAF) confirm the safety profile of XARELTO® (rivaroxaban) was generally consistent with the findings observed in ROCKET AF, the Phase 3 study that supported the approval of the medicine for prevention of stroke in patients with NVAF.

resources